Presenting Author
Idaho State University
As a Pharm.D. graduate and a Ph.D. candidate, I have always been equally enthusiastic about pharmacological science and clinical practice. During these years, my academic journey led me to understand the dedication and importance behind the development of a drug. I got to know how much effort and years of research and trial are put into designing a pill. Thus, I am eager to learn how the process of drug development works, from narrowing down thousands of molecular compounds to performing preclinical experiments for approval purposes.
The main focus of my Ph.D. projects is studying the renin-angiotensin system and its peptides, enzymes, and receptors components to understand how this system affects and is affected by different body systems. I independently developed and validated sensitive and selective LC-MS/MS methods allowing simultaneous quantification of 1) the renin-angiotensin system peptides and 2) arachidonic acid metabolites to measure their level in different disease states and compare them after treatment with the bone-targeted angiotensin-(1-7). I also have utilized a microfluidic method to develop and characterize the liposomal drug delivery of peptides and small molecules, such as jaspine B. I conducted pre-clinical pharmacokinetic studies to assess the distribution, metabolism, and elimination of small proteins, such as angiotensin-(1-7) and novokinin. I gained broad knowledge and related technical skills in various in vitro and in vivo studies. Currently, I am receiving training on using the Phoenix WinNonlin software for pharmacokinetic modeling and simulation and SAS statistical software for in-depth programming and analysis of the data. Overall, I am very collaborative and proficient in communication and interpersonal skills, have a good relationship with my colleagues, am experienced in teaching and holding leadership positions to guide groups of students, and am very open to new experiences and challenges.